TMTPOST -- Baichuan Intelligence, a Chinese AI company founded by Wang Xiaochuan, has unveiled a new financial-focused model, Baichuan4-Finance, which aims to revolutionize the financial sector by enhancing overall AI use cases with a focus on specialized expertise.
The model was developed using high-quality financial data and an industry-first self-constrained training approach, offering superior performance in financial scenarios, with accuracy levels surpassing that of GPT-4o by nearly 20%, said the company.
Baichuan Intelligence, founded in April 2023, has positioned itself as a leading AI company in China, aspiring to create the nation’s equivalent of OpenAI.
The company has released 16 large models to date, covering a range of fields, including open-source, academic research, and domestic computational power. Baichuan’s product lineup includes the Baichuan4-Turbo and Baichuan4-Air models, both of which contributed to its 1+3 product matrix, offering a comprehensive suite of solutions for AI commercialization.
The new Baichuan4-Finance model has already demonstrated impressive results, topping financial evaluation platforms such as FLAME and FinanceIQ. In tests, the model achieved an overall accuracy rate of 93.62%, significantly outpacing other models in areas like banking, insurance, and securities, said the company.
When discussing AI search, Wang said that while it may surpass Baidu's reach and even disrupt it, it still falls within the range of ByteDance's products.
Baichuan's full-link domain enhancement solution integrates high-quality data sets, pre-training, fine-tuning, and reinforcement learning into one unified system. This system ensures that the financial-specific capabilities of the model remain strong while maintaining its general AI strengths.
Baichuan has already partnered with several major companies, including Perfect World, iQIYI, and Huawei, gaining a solid foothold in industries like finance, gaming, and telecommunications. Looking forward, Wang sees AGI (Artificial General Intelligence) making rapid strides, with Baichuan at the forefront of this development.
"From a competition standpoint, we are still at a disadvantage within the realm of large companies' daily active users (DAUs). In many areas, we can't compete with smaller companies. Their sensitivity to market demands can dismantle mid-sized companies, as they possess strong competitiveness.
“Conversely, in the medical field, which is often seen as a niche, smaller companies might struggle. Although the previous generation has already invested 100 billion into it, many investors have lost confidence, yet investments continue to increase.
"As we transition from today's intelligent era to an era of life, the scope may become increasingly expansive. Healthcare is currently a particularly advantageous and unique position, but I believe that in three to five years, people will see it as more than a vertical direction. It may represent a broader future," Wang said.